CVS Health (CVS) PT Raised to $92 at Morgan Stanley
Tweet
Share
E-mailGet Alerts CVS Hot Sheet
Price: $94.28 -2.96%
Rating Summary:
34 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Rating Summary:
34 Buy, 5 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 18 | New: 20
Join SI Premium – FREE
Morgan Stanley analyst Ricky Goldwasser raised the price target on CVS Health (NYSE: CVS) to $92.00 (from $86.00) while maintaining a Overweight rating.
You May Also Be Interested In
- JPMorgan Upgrades Hyundai Marine and Fire Insurance (001450:KS) to Neutral
- JD Logistics Inc (2618:HK) (JDLGF) PT Raised to HK$18.50 at Macquarie
- Info Edge India (INFOE:IN) PT Raised to INR1,260 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
